Established in 1992 by Dr. Richard Jefferson, Cambia was originally an agricultural research institute. Two of the major achievements to come out of its laboratories were TransBacter, a work-around for the creation of transgenic plants without using the highly patented Agrobacterium genus, and the glucuronidase (GUS)-based transformation vectors, which in contrast to for-profit biotechnology companies are available without charge upon signing the open-source-inspired BiOS MTA (materials transfer agreement) (see BiOS).
The major work of the Patent Lens includes the free, full-text patent search engine, the Patent Lens, as well as several patent landscapes on important biotechnologies such as Agrobacterium, BASTA (a common herbicide) resistance, the human genome and the human telomerase gene. New patent landscapes are in the process of being created.
Voyager Learning Company to Combine with Cambium Learning to Create a Leading Provider of Educational Intervention Services.
Jul 11, 2009; Voyager Learning Company (Pink Sheets: VLCY), a publisher of education materials and provider of education solutions for the K-12...
Nautilus Neurosciences Announces U.S. Launch of CAMBIA Diclofenac Potassium for Oral Solution for the Treatment of Migraine.
Jun 23, 2010; Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in New Jersey, announced that...